I agree that this site is using cookies. You can find further informations here.
X
Lavé, Thierry
56  results:
Search for persons X
?
1

Use of Patient Health Records to Quantify Drug-Related Pro-..:

Davies, Mark R. ; Martinec, Michael ; Walls, Robert...
Cell Reports Medicine.  1 (2020)  5 - p. 100076 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Transforming preclinical assessment to meet clinical releva..:

Breous-Nystrom, Ekaterina ; Kronenberg, Sven ; Marrer-Berger, Estelle...
Current Opinion in Toxicology.  23-24 (2020)  - p. 39-45 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Real‐World Data and Physiologically‐Based Mechanistic Model..:

Wang, Ken ; Parrott, Neil ; Olivares‐Morales, Andres...
Clinical Pharmacology & Therapeutics.  107 (2020)  4 - p. 694-696 , 2020
Link: https://doi.org/10.1002/..
 
?
4

Model‐Informed Artificial Intelligence: Reinforcement Learn..:

Ribba, Benjamin ; Dudal, Sherri ; Lavé, Thierry.
Clinical Pharmacology & Therapeutics.  107 (2020)  4 - p. 853-857 , 2020
Link: https://doi.org/10.1002/..
 
?
5

Tailoring in silico model to electrophysiology of individua..:

Lei, Chon Lok ; Wang, Ken ; Gissinger, Evgenia...
Journal of Pharmacological and Toxicological Methods.  93 (2018)  - p. 144 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Comparison and assessment of CaV1.2 kinetics described by d..:

Wang, Ken ; Cooper, Jonathan ; Mirams, Gary...
Journal of Pharmacological and Toxicological Methods.  93 (2018)  - p. 147 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Importance of target-mediated drug disposition for small mo..:

Smith, Dennis A. ; van Waterschoot, Robert A.B. ; Parrott, Neil J....
Drug Discovery Today.  23 (2018)  12 - p. 2023-2030 , 2018
Link: https://doi.org/10.1016/..
 
?
8

PKPD modeling of acquired resistance to anti-cancer drug tr..:

Eigenmann, Miro J. ; Frances, Nicolas ; Lavé, Thierry.
Journal of Pharmacokinetics and Pharmacodynamics.  44 (2017)  6 - p. 617-630 , 2017
Link: https://doi.org/10.1007/..
 
?
9

Metabolic Profiling of Human Long-Term Liver Models and Hep..:

Kratochwil, Nicole A. ; Meille, Christophe ; Fowler, Stephen...
The AAPS Journal.  19 (2017)  2 - p. 534-550 , 2017
Link: https://doi.org/10.1208/..
 
?
10

What are the challenges and opportunities ahead of any regu..:

Davies, Mark ; Wang, Ken ; Caruso, Antonello...
Journal of Pharmacological and Toxicological Methods.  81 (2016)  - p. 349 , 2016
Link: https://doi.org/10.1016/..
 
?
11

Simulation-Based Evaluation of PK/PD Indices for Meropenem ..:

Kristoffersson, Anders N. ; David-Pierson, Pascale ; Parrott, Neil J....
Pharmaceutical Research.  33 (2016)  5 - p. 1115-1125 , 2016
Link: https://doi.org/10.1007/..
 
?
12

Importance of parameter control in cardiac models for robus..:

Wang, Ken ; Davies, Mark ; Caruso, Antonello...
Journal of Pharmacological and Toxicological Methods.  81 (2016)  - p. 361 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Recent developments in using mechanistic cardiac modelling ..:

Davies, Mark R. ; Wang, Ken ; Mirams, Gary R....
Drug Discovery Today.  21 (2016)  6 - p. 924-938 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Translational PK/PD modeling to increase probability of suc..:

Lavé, Thierry ; Caruso, Antonello ; Parrott, Neil.
Drug Discovery Today: Technologies.  21-22 (2016)  - p. 27-34 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Model-based assessment of erlotinib effect in vitro measure..:

Benay, Stephan ; Meille, Christophe ; Kustermann, Stefan...
Journal of Pharmacokinetics and Pharmacodynamics.  42 (2015)  3 - p. 275-285 , 2015
Link: https://doi.org/10.1007/..
 
1-15